ABSTRACT
Purpose
To use noninvasive fluorescence imaging to investigate the influence of molecular weight (MW) of proteins on the rate of loss from a subcutaneous (SC) injection site and subsequent uptake by the draining lymph nodes in mice.
Methods
Bevacizumab (149 kDa), bovine serum albumin (BSA, 66 kDa), ovalbumin (44.3 kDa) or VEGF-C156S (23 kDa), labeled with the near infrared dye IRDye 680, were injected SC into the front footpad of SKH-1 mice. Whole body non-invasive fluorescence imaging was performed to quantitate the fluorescence signal at the injection site and in axillary lymph nodes.
Results
The half-life values, describing the times for 50% loss of proteins from the injection site, were 6.81 h for bevacizumab, 2.85 h for BSA, 1.57 h for ovalbumin and 0.31 h for VEGF-C156S. The corresponding axillary lymph node exposure, represented as the area of the % dose versus time curve, was 6.27, 5.13, 4.06 and 1.54% dose ∙ h, respectively.
Conclusions
Our results indicate that the rate of loss of proteins from a SC injection site is inversely related to MW of proteins, while lymph node exposure is proportionally related to the MW of proteins in a mouse model.
Similar content being viewed by others
Abbreviations
- BSA:
-
bovine serum albumin
- FLN :
-
fraction of the dose recovered at the axillary lymph nodes
- FSC :
-
fraction of original signal remaining at the SC injection site
- IRDye:
-
infrared dye
- LN:
-
lymph node
- MW:
-
molecular weight
- ROI:
-
region of interest
- SC:
-
subcutaneous
- SDS-PAGE:
-
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
- VEGF:
-
vascular endothelial growth factor
REFERENCES
Porter CJ, Edwards GA, Charman SA. Lymphatic transport of proteins after s.c. injection: implications of animal model selection. Adv Drug Deliv Rev. 2001;50:157–71.
Jung M, Lees P, Seewald W, King JN. Analytical determination and pharmacokinetics of robenacoxib in the dog. J Vet Pharmacol Ther. 2009;32:41–8.
Supersaxo A, Hein WR, Steffen H. Effect of molecular weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration. Pharm Res. 1990;7:167–9.
Dreher MR, Liu W, Michelich CR, Dewhirst MW, Yuan F, Chilkoti A. Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. J Natl Cancer Inst. 2006;98:335–44.
Kagan L, Gershkovich P, Mendelman A, Amsili S, Ezov N, Hoffman A. The role of the lymphatic system in subcutaneous absorption of macromolecules in the rat model. Eur J Pharm Biopharm. 2007;67:759–65.
Cubas R, Zhang S, Kwon S, Sevick-Muraca EM, Li M, Chen C, et al. Virus-like particle (VLP) lymphatic trafficking and immune response generation after immunization by different routes. J Immunother. 2009;32:118–28.
Ding H, Yong KT, Law WC, Roy I, Hu R, Wu F, et al. Non-invasive tumor detection in small animals using novel functional Pluronic nanomicelles conjugated with anti-mesothelin antibody. Nanoscale. 2011;3:1813–22.
Ding H, Yong KT, Roy I, Hu R, Wu F, Zhao L, et al. Bioconjugated PLGA-4-arm-PEG branched polymeric nanoparticles as novel tumor targeting carriers. Nanotechnology. 2011;22:165101.
Yong KT, Roy I, Ding H, Bergey EJ, Prasad PN. Biocompatible near-infrared quantum dots as ultrasensitive probes for long-term in vivo imaging applications. Small. 2009;5:1997–2004.
Yong K-T, Hu R, Roy I, Ding H, Vathy LA, Bergey EJ, et al. Tumor targeting and imaging in live animals with functionalized semiconductor quantum rods. ACS Appl Mater Interfaces. 2009;1:710–9.
Kwon S, Sevick-Muraca EM. Noninvasive quantitative imaging of lymph function in mice. Lymphat Res Biol. 2007;5:219–31.
Gearing AJH, Thorpe SJ, Miller K, Mangan M, Varley PG, Dudgeon T, et al. Selective cleavage of human IgG by the matrix metalloproteinases, matrilysin and stromelysin. Immunol Lett. 2002;81:41–8.
Plasencia MD, Isailovic D, Merenbloom SI, Mechref Y, Novotny MV, Clemmer DE. Resolving and assigning N-linked glycan structural isomers from ovalbumin by IMS-MS. J Am Soc Mass Spectrom. 2008;19:1706–15.
Bhansali SG, Balu-Iyer SV, Morris ME. Influence of route of administration and liposomal encapsulation on blood and lymph node exposure to the protein VEGF-C156S. J Pharm Sci. 2011.
Porter CJ, Charman SA. Lymphatic transport of proteins after subcutaneous administration. J Pharm Sci. 2000;89:297–310.
Hong H, Sun J, Cai W. Multimodality imaging of nitric oxide and nitric oxide synthases. Free Radic Biol Med. 2009;47:684–98.
Kim BS, Oh JM, Hyun H, Kim KS, Lee SH, Kim YH, et al. Insulin-loaded microcapsules for in vivo delivery. Mol Pharm. 2009;6:353–65.
Kim BS, Oh JM, Kim KS, Seo KS, Cho JS, Khang G, et al. BSA-FITC-loaded microcapsules for in vivo delivery. Biomaterials. 2009;30:902–9.
Wu F, Wuensch SA, Azadniv M, Ebrahimkhani MR, Crispe IN. Galactosylated LDL nanoparticles: a novel targeting delivery system to deliver antigen to macrophages and enhance antigen specific T cell responses. Mol Pharm. 2009;6:1506–17.
Lu ZR. Molecular imaging of HPMA copolymers: visualizing drug delivery in cell, mouse and man. Adv Drug Deliv Rev. 2010;62:246–57.
Erogbogbo F, Yong KT, Roy I, Hu R, Law WC, Zhao W, et al. In vivo targeted cancer imaging, sentinel lymph node mapping and multi-channel imaging with biocompatible silicon nanocrystals. ACS Nano. 2011;5:413–23.
Ballou B, Ernst LA, Andreko S, Harper T, Fitzpatrick JA, Waggoner AS, et al. Sentinel lymph node imaging using quantum dots in mouse tumor models. Bioconjug Chem. 2007;18:389–96.
Koyama Y, Talanov VS, Bernardo M, Hama Y, Regino CA, Brechbiel MW, et al. A dendrimer-based nanosized contrast agent dual-labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice. J Magn Reson Imaging. 2007;25:866–71.
Kim D, Lee ES, Park K, Kwon IC, Bae YH. Doxorubicin loaded pH-sensitive micelle: antitumoral efficacy against ovarian A2780/DOXR tumor. Pharm Res. 2008;25:2074–82.
Zou P, Xu S, Povoski SP, Wang A, Johnson MA, Martin Jr EW, et al. Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice. Mol Pharm. 2009;6:428–40.
Hu R, Yong KT, Roy I, Ding H, Law WC, Cai H, et al. Functionalized near-infrared quantum dots for in vivo tumor vasculature imaging. Nanotechnology. 2010;21:145105.
Diagaradjane P, Orenstein-Cardona JM, Colon-Casasnovas NE, Deorukhkar A, Shentu S, Kuno N, et al. Imaging epidermal growth factor receptor expression in vivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe. Clin Cancer Res. 2008;14:731–41.
Fox GB, Chin CL, Luo F, Day M, Cox BF. Translational neuroimaging of the CNS: novel pathways to drug development. Mol Interv. 2009;9:302–13.
Prajapati SI, Martinez CO, Bahadur AN, Wu IQ, Zheng W, Lechleiter JD, et al. Near-infrared imaging of injured tissue in living subjects using IR-820. Mol Imaging. 2009;8:45–54.
Koning GA, Krijger GC. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery. Anticancer Agents Med Chem. 2007;7:425–40.
Kumar R, Roy I, Ohulchanskky TY, Vathy LA, Bergey EJ, Sajjad M, et al. In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano. 2010;4:699–708.
Barrett T, Choyke PL, Kobayashi H. Imaging of the lymphatic system: new horizons. Contrast Media Mol Imaging. 2006;1:230–45.
Weissleder R. Scaling down imaging: molecular mapping of cancer in mice. Nat Rev Cancer. 2002;2:11–8.
Wang H, Chen K, Niu G, Chen X. Site-specifically biotinylated VEGF(121) for near-infrared fluorescence imaging of tumor angiogenesis. Mol Pharm. 2009;6:285–94.
Zou P, Xu S, Wang A, Povoski S, Johnson M, Martin E, et al. Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice. Mol Pharm. 2009.
Engeset A. The route of peripheral lymph to the blood stream; an x-ray study of the barrier theory. J Anat. 1959;93:96–100.
Kubik S. Anatomy of the lymphatic system. In: Foldi M, Foldi E, Kubik S, editors. Textbook of lymphology. San Francisco: Elsevier GmbH; 2003. p. 1–166.
Hildebrandt P. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors. Dan Med Bull. 1991;38:337–46.
Kang S, Brange J, Burch A, Volund A, Owens DR. Subcutaneous insulin absorption explained by insulin’s physicochemical properties. Evidence from absorption studies of soluble human insulin and insulin analogues in humans. Diabetes Care. 1991;14:942–8.
Charman SA, McLennan DN, Edwards GA, Porter CJ. Lymphatic absorption is a significant contributor to the subcutaneous bioavailability of insulin in a sheep model. Pharm Res. 2001;18:1620–6.
Harvey AJ, Kaestner SA, Sutter DE, Harvey NG, Mikszta JA, Pettis RJ. Microneedle-based intradermal delivery enables rapid lymphatic uptake and distribution of protein drugs. Pharm Res. 2011;28:107–16.
ACKNOWLEDGMENTS & DISCLOSURES
This work is supported by a grant from the University at Buffalo Center for Protein Therapeutics to MEM. SGB was supported in part by a fellowship from Pfizer Global Research and Development. We acknowledge the valuable assistance from Dr. Rajiv Kumar, Lisa A. Vathy, Dr. Hong Ding, and Dr. Ken-Tye Yong from the Institute for Lasers, Photonics and Biophotonics, University at Buffalo.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wu, F., Bhansali, S.G., Law, W.C. et al. Fluorescence Imaging of the Lymph Node Uptake of Proteins in Mice after Subcutaneous Injection: Molecular Weight Dependence. Pharm Res 29, 1843–1853 (2012). https://doi.org/10.1007/s11095-012-0708-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-012-0708-6